Novais T, Garnier-Crussard A, Haouari S, Rocquain J, Soler CF, Mondet L, Marquant B, Legrand M, Novella JL, Lepelletier A, Bureau ML, Coutauchaud M, Mosnier-Thoumas S, Gervais F
Geriatr Psychol Neuropsychiatr Vieil. 2026 Jun 1;24(2):220-229.
PMID: 42412506
ABSTRACT
In 2025, an Irish team developed the STOPPCog criteria to identify and support the deprescribing of potentially inappropriate medications (PIMs) in cognitively vulnerable older adults. The aim of this study was to provide a French adaptation of the STOPPCog criteria to facilitate their use by French healthcare professionals. The cross-cultural adaptation into French was conducted by two experts, confirmed through a forward-backward translation process, and finalized based on feedback from ten French reviewers (geriatricians and clinical pharmacists). Validation was performed by assessing inter-rater agreement using the intraclass correlation coefficient (ICC) after application of the STOPPCog criteria to five standardized clinical vignettes. The 23 criteria of the STOPPCog tool, organized into six sections, were retained with the same classification as in the original English version, while being adapted to French clinical practice. Back-translation confirmed preservation of the original clinical meaning, and good agreement among the ten reviewers was observed for the identification of PIMs (ICC = 0.791). The French adaptation of the STOPPCog criteria represents an important step toward facilitating their implementation in France. Adjustments based on recent French guidelines and the literature strengthen its relevance in the national context. Future work should focus on facilitating its implementation in clinical practice.
Keywords: France; STOPPCog; cognition; older people; potentially inappropriate medication.
